Hinge Health, Inc.
Overview
Deal Type |
Equity Capital Markets |
---|---|
Size |
$502.9 Million Initial Public Offering |
Client & Transactional Partners |
Hinge Health, Inc. |
Our Role |
Joint Bookrunner |
Summary
On May 21, 2025, KeyBanc Capital Markets served as Joint Bookrunner on Hinge Health, Inc.’s (Hinge Health or the Company) $502.9 million Initial Public Offering of 15,715,900 shares, including overallotment.
Headquartered in San Francisco, California, Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for its clients. The Company has designed its platform to address a broad spectrum of MSK care – from acute injury, to chronic pain, to post-surgical rehabilitation. The platform helps ease members’ pain, improve their function, and reduce their need for surgeries, all while driving health equity by enabling members to engage in their exercise therapy sessions from anywhere.
KeyBanc Capital Markets is a trade name under which the corporate and investment banking products and services of KeyCorp and its subsidiaries, KeyBanc Capital Markets Inc., member FINRA/SIPC (“KBCMI”), and KeyBank National Association (“KeyBank N.A.”), are marketed. Securities products and services are offered by KeyBanc Capital Markets Inc. and by its licensed securities representatives. Banking products and services are offered by KeyBank N.A.